A way to target a drug to a specific tissue. The drug is administered as an inactive pro-drug, and then converted into an active drug by an enzyme administered with a second injection. The enzyme is coupled to an antibody that concentrates it in the target tissue. When the enzyme arrives at the target tissue, the pro-drug is activated to form the active drug, while elsewhere it remains inactive.